Acute orexigenic effect of agmatine involves interaction between central α2-adrenergic and GABAergic receptors
Copyright © 2017 Elsevier Masson SAS. All rights reserved..
Agmatine and GABA have been abundantly expressed in brain nuclei involved in regulation of energy homeostasis and promoting stimulation of food intake in rodents. However, their mutual interaction, if any, in the elicitation of feeding behavior is largely remains unclear. The current study provides experimental evidence for the possible interaction of agmatine, adrenergic and GABAergic systems in stimulation of feeding in satiated rats. Satiated rats fitted with intracerebroventricular (i.c.v.) cannulae and were administered agmatine, alone or jointly with (a) GABAA receptor agonist, muscimol, diazepam or antagonist bicuculline and flumazenil, GABAA positive modulator, allopregnanolone or negative modulator of GABAA receptor, dehydroepiandrosterone (b) In view of the high affinity of agmatine for α2-adrenoceptors and the close association between α2-adrenoceptors and GABAergic system, the effect of their modulators on feeding elicited by agmatine/GABAergic agonists were also examined. I.c.v. administration of agmatine (40-80μg/rat) induces the significant orexigenic effect in satiated rats. The orexigenic effect of agmatine was potentiated by muscimol (25ng/rat, i.c.v.); diazepam (0.5mg/kg, i.p.); allopregnanolone (0.5mg/kg, s.c.) and blocked by bicuculline (1mg/kg, i.p.) and dehydroepiandrosterone (4mg/kg,s.c.). However, it remained unaffected in presence of flumazenil (25ng/rat, i.c.v.). The orexigenic effect of agmatine and GABAergic agonists was potentiated by a α2-adrenoceptors agonist, clonidine (10ng/rat, i.c.v.) and blocked by its antagonist, yohimbine (5μg/rat, i.c.v.). Yohimbine also blocked the hyperphagic effect elicited by ineffective dose combination of agmatine (5μg/rat, i.c.v.) with muscimol (25ng/rat, i.c.v.) or diazepam (0.5mg/kg, i.p.) or allopregnanolone (0.5mg/kg,s.c.). The results of the present study suggest that agmatine induced α2-adrenoceptors activation might facilitate GABAergic activity to stimulate food intake in satiated rats.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:93 |
---|---|
Enthalten in: |
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 93(2017) vom: 01. Sept., Seite 939-947 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Taksande, Brijesh Gulabrao [VerfasserIn] |
---|
Links: |
---|
Themen: |
α(2)-adrenoceptors |
---|
Anmerkungen: |
Date Completed 25.04.2018 Date Revised 25.04.2018 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.biopha.2017.07.004 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM273915452 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM273915452 | ||
003 | DE-627 | ||
005 | 20231225002320.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.biopha.2017.07.004 |2 doi | |
028 | 5 | 2 | |a pubmed24n0913.xml |
035 | |a (DE-627)NLM273915452 | ||
035 | |a (NLM)28715875 | ||
035 | |a (PII)S0753-3322(17)31269-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Taksande, Brijesh Gulabrao |e verfasserin |4 aut | |
245 | 1 | 0 | |a Acute orexigenic effect of agmatine involves interaction between central α2-adrenergic and GABAergic receptors |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.04.2018 | ||
500 | |a Date Revised 25.04.2018 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2017 Elsevier Masson SAS. All rights reserved. | ||
520 | |a Agmatine and GABA have been abundantly expressed in brain nuclei involved in regulation of energy homeostasis and promoting stimulation of food intake in rodents. However, their mutual interaction, if any, in the elicitation of feeding behavior is largely remains unclear. The current study provides experimental evidence for the possible interaction of agmatine, adrenergic and GABAergic systems in stimulation of feeding in satiated rats. Satiated rats fitted with intracerebroventricular (i.c.v.) cannulae and were administered agmatine, alone or jointly with (a) GABAA receptor agonist, muscimol, diazepam or antagonist bicuculline and flumazenil, GABAA positive modulator, allopregnanolone or negative modulator of GABAA receptor, dehydroepiandrosterone (b) In view of the high affinity of agmatine for α2-adrenoceptors and the close association between α2-adrenoceptors and GABAergic system, the effect of their modulators on feeding elicited by agmatine/GABAergic agonists were also examined. I.c.v. administration of agmatine (40-80μg/rat) induces the significant orexigenic effect in satiated rats. The orexigenic effect of agmatine was potentiated by muscimol (25ng/rat, i.c.v.); diazepam (0.5mg/kg, i.p.); allopregnanolone (0.5mg/kg, s.c.) and blocked by bicuculline (1mg/kg, i.p.) and dehydroepiandrosterone (4mg/kg,s.c.). However, it remained unaffected in presence of flumazenil (25ng/rat, i.c.v.). The orexigenic effect of agmatine and GABAergic agonists was potentiated by a α2-adrenoceptors agonist, clonidine (10ng/rat, i.c.v.) and blocked by its antagonist, yohimbine (5μg/rat, i.c.v.). Yohimbine also blocked the hyperphagic effect elicited by ineffective dose combination of agmatine (5μg/rat, i.c.v.) with muscimol (25ng/rat, i.c.v.) or diazepam (0.5mg/kg, i.p.) or allopregnanolone (0.5mg/kg,s.c.). The results of the present study suggest that agmatine induced α2-adrenoceptors activation might facilitate GABAergic activity to stimulate food intake in satiated rats | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Agmatine | |
650 | 4 | |a Food intake | |
650 | 4 | |a GABA | |
650 | 4 | |a Satiated rats | |
650 | 4 | |a α(2)-adrenoceptors | |
650 | 7 | |a Adrenergic alpha-2 Receptor Agonists |2 NLM | |
650 | 7 | |a GABA Agonists |2 NLM | |
650 | 7 | |a Receptors, Adrenergic, alpha-2 |2 NLM | |
650 | 7 | |a Receptors, GABA-A |2 NLM | |
650 | 7 | |a Agmatine |2 NLM | |
650 | 7 | |a 70J407ZL5Q |2 NLM | |
700 | 1 | |a Sharma, Omi |e verfasserin |4 aut | |
700 | 1 | |a Aglawe, Manish Manohar |e verfasserin |4 aut | |
700 | 1 | |a Kale, Mayur Bhimrao |e verfasserin |4 aut | |
700 | 1 | |a Gawande, Dinesh Yugraj |e verfasserin |4 aut | |
700 | 1 | |a Umekar, Milind Janraoji |e verfasserin |4 aut | |
700 | 1 | |a Kotagale, Nandkishor Ramdas |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie |d 1984 |g 93(2017) vom: 01. Sept., Seite 939-947 |w (DE-627)NLM012645591 |x 1950-6007 |7 nnns |
773 | 1 | 8 | |g volume:93 |g year:2017 |g day:01 |g month:09 |g pages:939-947 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.biopha.2017.07.004 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 93 |j 2017 |b 01 |c 09 |h 939-947 |